D-0169-2023 Class II Terminated

Recalled by Ascend Laboratories, LLC — Parsippany, NJ

FDA drug recall D-0169-2023 was initiated by Ascend Laboratories, LLC on Jan 5, 2023 and is designated Class II. Reason for recall: Failed Dissolution Specification The recall status is terminated (terminated Aug 15, 2024). Affected quantity: 49,632 bottles.

Recall details

Product Type
Drugs
Report Date
Feb 1, 2023
Initiation Date
Jan 5, 2023
Termination Date
Aug 15, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
49,632 bottles

Product description

Metoprolol Succinate Extended-Release Tablets, USP 25 mg, Rx Only, 100 Tablets per bottle, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC, Parsippany NJ 07054, NDC 67877-590-01.

Reason for recall

Failed Dissolution Specification

Distribution pattern

Nationwide and Puerto Rico

Code information

Lot #s: 21143094, 21143095, 21143119, 21143121, 21142389, Exp 03/31/2023.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0169-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0169-2023. Report a data issue: hello@regdatalab.com.